Clinical Trial Update: Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting efficacy and safety data for ASAQ and PD in treating uncomplicated falciparum malaria in mainland Tanzania.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Malaria Due to Plasmodium Falciparum

Drugs mentioned

• ASAQ (amodiaquine-artesunate)
• PD

Snippet

Sponsor: National Institute for Medical Research, Tanzania | Conditions: Uncomplicated Falciparum Malaria | Phase 4 | Status: COMPLETED